PortfoliosStock ScreensStocksStockXcel

Interface Inc

TILE | US

28.13

USD

-0.27

-0.95%

TILE | US

About Interface Inc

Sector

Consumer Cyclical

Industry

Textile Manufacturing

Earnings date

30/06/2024

As of date

21/04/2026

Close

28.13

Open

28.56

High

28.95

Low

28.06

Interface Inc. designs produces and sells modular carpet products primarily in the United States and internationally. The company operates in two segments Americas (AMS) and Europe Africa Asia and Australia (EAAA). The company offers modular carpets under the Interface and FLOR brand names; luxury vinyl tiles and vinyl sheet under the Interface brand; carpet tiles under the CQuestGB name for use in commercial interiors include offices healthcare facilities airports educational and other institutions hospitality spaces and retail facilities as well as residential interiors; and modular resilient flooring products. It also provides carpet replacement installation and maintenance services; and rubber flooring under the norament and noraplan brand names. The company produces and sells an adapted version of its carpet tile for the healthcare facilities market. In addition it sells a proprietary antimicrobial chemical compound under the Intersept name; sells TacTiles a carpet tile installation system as well as various adhesives and products; and provides turnkey project management services for global accounts and other customers through its InterfaceSERVICES business. The company sells its products directly to end-users as well as indirectly through independent contractors installers or distributors. Interface Inc. was incorporated in 1973 and is headquartered in Atlanta Georgia.

View Less

TILE | US

Risk
37.7
Sharpe
1.31
Luna's Score
51/100
Recommendation
Hold

Luna says (TILE | US)

What's Working

Positive Momentum

Value Stock (Price to Book < 3)

Strong Sharpe Ratio (> 1.2)

What's not Working

Weakness based on declining price with high volume

High Short-term Volatility

Smallcap (300M - 2B USD)

High Market Beta (> 0.8)

High Debt to Equity (> 0.75)

Volatility Signals

Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.

Risk Meter

10 days

38.4%

1 month

37.7%

3 months

33.1%

6 months

31.0%

Returns

Fundamental Ratios

PE

17.81

Fwd. PE

14.53

Price to book

2.60

Debt to equity

1.06

Debt to assets

0.39

Ent. to EBITDA

9.33

Ent. to rev.

1.22

PEG

0.97

Other Fundamentals

EBITDA

171.17M

MarketCap

1.64B

MarketCap(USD)

1.64B

Div. yield

0.20

Op. margin

10.72

Erngs. growth

41.40

Rev. growth

5.20

Ret. on equity

15.83

Short ratio

1.28

Short perc.

1.90

Market Sentiment (SMA and Price signals)

Short-term: Bullish (SMA10D > SMA1M)

Intermediate-term: Bearish (SMA1M < SMA3M)

Long-term: Bullish (SMA6M > SMA12M)

SMAs: Stock Price Trends

Range10D

4.36

Range1M

4.55

Range3M

10.71

Volumes: Market Activity

Rel. volume

1.06

Price X volume

21.70M

Peers

Name
Ticker
Industry
Close
Marketcap
Day Return
PE Ratio
Debt to Equity
 
 
 
 
 
 
 
 
No data

Diversifiers

Name
Ticker
Industry
Close
Marketcap
Day Return
PE Ratio
Debt to Equity
 
 
 
 
 
 
 
 
Assertio Therapeutics IncASRTDrug Manufacturers-Specialty & Generic18.021.72B-0.66%n/a30.76%
Perrigo Company plcPRGODrug Manufacturers-Specialty & Generic11.731.60B-2.57%n/a93.52%
Harrow Health IncHROWDrug Manufacturers-Specialty & Generic39.451.40B-2.59%n/a331.16%
Clover Leaf Financial CorpCLOVHealthcare Plans2.391.19B7.17%n/a1.23%
Karyopharm Therapeutics IncKPTIDrug Manufacturers-Specialty & Generic9.171.14B2.57%n/a-148.05%
Pacira Pharmaceuticals IncPCRXDrug Manufacturers-Specialty & Generic24.641.14B-1.04%13.0573.76%
Collegium Pharmaceutical IncCOLLDrug Manufacturers-Specialty & Generic33.271.07B-3.03%14.45258.31%
Alvotech Ordinary SharesALVODrug Manufacturers-Specialty & Generic3.511.06B-3.04%n/a-196.14%
Amphastar Pharmaceuticals IncAMPHDrug Manufacturers-Specialty & Generic21.211.04B-7.46%16.1487.00%
OPKO Health IncOPKDrug Manufacturers-Specialty & Generic1.22844.22M0.00%n/a19.31%
  • 1

Industry Comparison

ParameterCompanyIndustryIndicator
Enterprise to EBITDA9.33--
Ent. to Revenue1.22--
PE Ratio17.81--
Price to Book2.60--
Dividend Yield0.20--
Std. Deviation (3M)33.06--
Debt to Equity1.06--
Debt to Assets0.39--
Market Cap1.64B--
  • 1

Unlock Your Investing Potential

Register with Xstocks

Join over 2,000+ Investors

Register now and embark on your journey to informed and successful investing.

Explore Industry Correlations

Explore Industry Correlations

Uncover Trading and Hedging Opportunities

Gain valuable insights into potential trading opportunities and discover strategic hedging possibilities

Discover Top-Performing Industries

Discover Top performing Industries

Explore Stocks for Short and Long-Term Gains

Uncover opportunities at both short-term and long-term horizons, allowing you to make informed investment decisions.

Follow us @XStocks007